National Institute on Minority Health and Health Disparities
OrganisationROR
Trials
Barber and Pharmacist Coordination to Improve Blood Pressure Management
CollaboratorNo phaseNot yet recruiting202655 people5 Oct 2026clinicaltrials.gov
Improving Sleep Health for Asian Americans
CollaboratorNo phaseNot yet recruiting202640 people30 Sept 2026clinicaltrials.gov
CollaboratorPhase 2Recruiting2026210 people25 Sept 2026clinicaltrials.gov
Actívatexto: Advancing Smoking Cessation and Physical Activity Among Latinos
CollaboratorNo phaseRecruiting2025408 people13 Apr 2025clinicaltrials.gov
CollaboratorNo phaseCompleted2025100 people10 Jan 2025clinicaltrials.gov
CollaboratorPhase 1/2Recruiting202699 people27 Sept 2024clinicaltrials.gov
CollaboratorNo phaseRecruiting2024290 people19 Sept 2024clinicaltrials.gov
Scaling Telehealth Models to Improve Co-morbid Diabetes and Hypertension (Phase II)
CollaboratorNo phaseEnrolling by invitation2024450 people7 Aug 2024clinicaltrials.gov
Remotely Delivered Mindfulness-Based Diabetes Education
CollaboratorNo phaseNot yet recruiting202680 people15 Mar 2024clinicaltrials.gov
Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED)
CollaboratorNo phaseRecruiting20231,176 people15 Nov 2023clinicaltrials.gov
CollaboratorPhase 4Withdrawn20230 people24 Aug 2023clinicaltrials.gov
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
CollaboratorNo phaseActive, not recruiting2023454 people19 Dec 2022clinicaltrials.gov
CollaboratorPhase 4Terminated2018114 people23 Aug 2017clinicaltrials.gov
CollaboratorPhase 3Completed19962,779 people5 Jun 2002clinicaltrials.gov
CollaboratorPhase 3Completed19963,234 people20 Mar 2000clinicaltrials.gov
CollaboratorPhase 3Completed1994711 people14 Mar 2000clinicaltrials.gov
Awards made
R01Resistance Exercise Training in Middle-aged Women Targeting Blood Pressure and Vascular HealthR01MD0218692026–20319 Sept 2026reporter.nih.gov
R01Resistance Exercise Training in Middle-aged Women Targeting Blood Pressure and Vascular HealthR01MD0218692026–20319 Sept 2026reporter.nih.gov
Univ of Maryland, College Park
R01Resistance Exercise Training in Middle-aged Women Targeting Blood Pressure and Vascular HealthR01MD021869US$769.6k2026–20319 Sept 2026reporter.nih.gov
R21Socio Economic Disparities in Type 2 Diabetes in African American Populations: a Proteomic Approach to Identify Biological PathwaysR21MD0204572026–20289 Sept 2026reporter.nih.gov
R21Socio Economic Disparities in Type 2 Diabetes in African American Populations: a Proteomic Approach to Identify Biological PathwaysR21MD020457US$216.7k2026–20289 Sept 2026reporter.nih.gov
R01Aina-Based Engagement and Social Epigenomic Pathways to Metabolic Health in Native Hawaiian YouthR01MD0218562026–20315 Sept 2026reporter.nih.gov
R01Aina-Based Engagement and Social Epigenomic Pathways to Metabolic Health in Native Hawaiian YouthR01MD0218562026–20315 Sept 2026reporter.nih.gov
R01Aina-Based Engagement and Social Epigenomic Pathways to Metabolic Health in Native Hawaiian YouthR01MD021856US$712.2k2026–20315 Sept 2026reporter.nih.gov
R01Genetic Determinants of Cardiovascular-Kidney-Metabolic SyndromeR01MD0216482026–20313 Sept 2026reporter.nih.gov
R01Genetic Determinants of Cardiovascular-Kidney-Metabolic SyndromeR01MD0216482026–20313 Sept 2026reporter.nih.gov
R01Genetic Determinants of Cardiovascular-Kidney-Metabolic SyndromeR01MD0216482026–20313 Sept 2026reporter.nih.gov
R01Genetic Determinants of Cardiovascular-Kidney-Metabolic SyndromeR01MD021648US$770k2026–20313 Sept 2026reporter.nih.gov
R01Lifestyle strategies to preserve muscle and reduce cardiovascular risk in adults with obesity using GLP-1 receptor agonistsR01MD0216562026–20311 Sept 2026reporter.nih.gov
R01Lifestyle strategies to preserve muscle and reduce cardiovascular risk in adults with obesity using GLP-1 receptor agonistsR01MD0216562026–20311 Sept 2026reporter.nih.gov
R01Lifestyle strategies to preserve muscle and reduce cardiovascular risk in adults with obesity using GLP-1 receptor agonistsR01MD021656US$734.8k2026–20311 Sept 2026reporter.nih.gov
R21A generalizable framework for the development of a Continuous Metabolic Syndrome Risk Score in small populations.R21MD0215642026–20281 Sept 2026reporter.nih.gov
R21A generalizable framework for the development of a Continuous Metabolic Syndrome Risk Score in small populations.R21MD0215642026–20281 Sept 2026reporter.nih.gov
University of Alabama at Birmingham
R21A generalizable framework for the development of a Continuous Metabolic Syndrome Risk Score in small populations.R21MD021564US$201.4k2026–20281 Sept 2026reporter.nih.gov
R01Public Health Insurance and Mortality Among People with DisabilitiesR01MD0204022026–20311 Sept 2026reporter.nih.gov
R01Public Health Insurance and Mortality Among People with DisabilitiesR01MD0204022026–20311 Sept 2026reporter.nih.gov
Funded papers
26 Sept 2026api.crossref.org
Loneliness and all-cause mortality in the United States
U54MD00759725 Sept 2026api.crossref.org
LDL-C equation disagreement as a threshold-integrity flag for orthogonal lipid confirmation
U54MD00759714 Sept 2026api.crossref.org
Papers
The journals of gerontology. Series B, Psychological sciences and social sciences6 Oct 2026
US study finds lasting Black–White gaps in local conditions
The journals of gerontology. Series B, Psychological sciences and social sciences6 Oct 2026
Health worsened as US adults in a study reached midlife
The journals of gerontology. Series B, Psychological sciences and social sciences6 Oct 2026
LDL-C equation disagreement as a threshold-integrity flag for orthogonal lipid confirmation
Journal of clinical lipidology30 Sept 2026